001     282336
005     20240229155038.0
024 7 _ |a 10.1038/s41467-023-40822-9
|2 doi
024 7 _ |a pmid:37626054
|2 pmid
024 7 _ |a pmc:PMC10457401
|2 pmc
024 7 _ |a altmetric:153396546
|2 altmetric
037 _ _ |a DKFZ-2023-01720
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Bailey, Peter
|b 0
245 _ _ |a Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression.
260 _ _ |a [London]
|c 2023
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1693227813_1865
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The molecular basis of disease progression from UV-induced precancerous actinic keratosis (AK) to malignant invasive cutaneous squamous cell carcinoma (cSCC) and potentially lethal metastatic disease remains unclear. DNA sequencing studies have revealed a massive mutational burden but have yet to illuminate mechanisms of disease progression. Here we perform RNAseq transcriptomic profiling of 110 patient samples representing normal sun-exposed skin, AK, primary and metastatic cSCC and reveal a disease continuum from a differentiated to a progenitor-like state. This is accompanied by the orchestrated suppression of master regulators of epidermal differentiation, dynamic modulation of the epidermal differentiation complex, remodelling of the immune landscape and an increase in the preponderance of tumour specific keratinocytes. Comparative systems analysis of human cSCC coupled with the generation of genetically engineered murine models reveal that combinatorial sequential inactivation of the tumour suppressor genes Tgfbr2, Trp53, and Notch1 coupled with activation of Ras signalling progressively drives cSCC progression along a differentiated to progenitor axis. Taken together we provide a comprehensive map of the cSCC disease continuum and reveal potentially actionable events that promote and accompany disease progression.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Ridgway, Rachel A
|0 0000-0003-0198-8244
|b 1
700 1 _ |a Cammareri, Patrizia
|b 2
700 1 _ |a Treanor-Taylor, Mairi
|0 0000-0002-8908-3900
|b 3
700 1 _ |a Bailey, Ulla-Maja
|0 0000-0003-3641-9252
|b 4
700 1 _ |a Schoenherr, Christina
|0 0000-0002-0983-6168
|b 5
700 1 _ |a Bone, Max
|0 0000-0001-8589-3343
|b 6
700 1 _ |a Schreyer, Daniel
|0 0000-0002-9788-0168
|b 7
700 1 _ |a Purdie, Karin
|b 8
700 1 _ |a Thomson, Jason
|b 9
700 1 _ |a Rickaby, William
|b 10
700 1 _ |a Jackstadt, Rene
|0 P:(DE-He78)5da14633266cbfff7746cf529c110673
|b 11
|u dkfz
700 1 _ |a Campbell, Andrew D
|0 0000-0003-3930-1276
|b 12
700 1 _ |a Dimonitsas, Emmanouil
|b 13
700 1 _ |a Stratigos, Alexander J
|b 14
700 1 _ |a Arron, Sarah T
|0 0000-0001-5669-0627
|b 15
700 1 _ |a Wang, Jun
|0 0000-0003-2509-9599
|b 16
700 1 _ |a Blyth, Karen
|0 0000-0002-9304-439X
|b 17
700 1 _ |a Proby, Charlotte M
|0 0000-0002-3292-4836
|b 18
700 1 _ |a Harwood, Catherine A
|b 19
700 1 _ |a Sansom, Owen J
|0 0000-0001-9540-3010
|b 20
700 1 _ |a Leigh, Irene M
|0 0000-0001-8536-6439
|b 21
700 1 _ |a Inman, Gareth J
|0 0000-0002-6264-4253
|b 22
773 _ _ |a 10.1038/s41467-023-40822-9
|g Vol. 14, no. 1, p. 5211
|0 PERI:(DE-600)2553671-0
|n 1
|p 5211
|t Nature Communications
|v 14
|y 2023
|x 2041-1723
909 C O |o oai:inrepo02.dkfz.de:282336
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)5da14633266cbfff7746cf529c110673
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2023
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-10-13T14:44:21Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-11
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2022-11-11
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2022-11-11
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:09:09Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2023-08-29
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
920 1 _ |0 I:(DE-He78)A014-20160331
|k A014
|l NWG Metastatische Nischen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A014-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21